Alerts will be sent to your verified email
Verify EmailASTEC
Balance sheet of Astec Lifesciences is moderately strong, But short term working capital might become an issue for this company.
Yes, The net debt of Astec Lifesciences is increasing.
Latest net debt of Astec Lifesciences is ₹549 Crs as of Mar-25.
This is greater than Mar-24 when it was ₹489 Crs.
The profit is oscillating.
The profit of Astec Lifesciences is -₹128.03 Crs for TTM, -₹134.75 Crs for Mar 2025 and -₹46.93 Crs for Mar 2024.
The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Astec Lifesciences latest dividend payout ratio is 11.5% and 3yr average dividend payout ratio is 11.5%
Companies resources are majorly tied in miscellaneous assets